Abstract
Genetic linkage studies worldwide have proposed various chromosomal localizations for prostate cancer susceptibility genes. A recent study found evidence for linkage to chromosome 1q42.2–43. The aim of our study was to attempt to confirm these findings by performing linkage analysis in 131 families with multiple prostate cancer cases selected from the ACTANE (Anglo, Canada, Texas, Australia, Norway, EU Biomed) Consortium. Parametric and non-parametric linkage (NPL) analyses were performed. Two-point LOD scores failed to show evidence of linkage at any marker (maximum two-point LOD score = 0.40 at recombination fraction θ = 0.2 with marker D1S2850). Using a multipoint heterogeneity analysis, the estimated proportion of families linked to this putative locus (α) was 0% (95% CI = 0.00–0.33). Non-parametric linkage analysis also found no evidence of linkage (maximum NPL score = –0.12, P = 0.55). This analysis of 131 ACTANE families does not support the presence of a locus for a prostate cancer susceptibility gene at 1q42.2–43. Although we cannot rule out the existence of such a locus, analysis indicates that less than 16% of families could be linked to this region. These findings may be a reflection of the locus heterogeneity involved in this disease indicating that there are still other major susceptibility loci to be identified. © 2000 Cancer Research Campaign http://www.bjcancer.com
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Berthon P, Valeri A, Cohen-Akenine,, Drelon E, Paiss T, Wohr G, Latil A, Millasseau P, Mellah I, Cohen N, Blanche H, Bellane-Chantelot C, Demenais F, Teillac P, Le Duc A, de Petriconi R, Hautmann R, Chumakov I, Bachner L, Maitland NJ, Lidereau R, Vogel W, Fournier G, Mangin P and Cussenot O (1998) Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2–43. Am J Hum Genet 62: 1416–1424
Broman KW, Murray JC, Sheffield VC, White RL and Weber JL (1998) Comprehensive human genetic maps: individual and sex-specific variation in recombination. Am J Hum Genet 63: 861–869
Cannon-Albright L and Neuhausen S (1997) Prostate cancer susceptibility locus on chromosome 1 examined in Utah kindreds. Paper presented at. Genetic Approaches to Breast and Prostate Cancer Cambridge Symposia, March 22–April 17: Cambridge
Carter BS, Beaty TH, Steinberg GD, Childs B and Walsh PC (1992) Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA 89: 3367–3371
Cooney KA, McCarthy JD, Lange E, Huang L, Miesfeldt S, Montie JE, Osterling JE, Sandler HM and Lange K (1997) Prostate cancer susceptibility locus on chromosome 1q: a confirmatory study. J Natl Cancer Inst 89: 955–959
Cottingham RW, Jr, Idury RM and Schäffer AA (1993) Faster sequential genetic linkage computations. Am J Hum Genet 53: 252–263
Dausset J, Cann H, Cohen D, Lathrop M, Lalouel JM and White R (1990) Centre d'etude du polymorphisme humain (CEPH): collaborative genetic mapping of the human genome. Genomics 6: 575–577
Eeles RA, Durocher F, Edwards S, Teare D, Badzioch M, Hamoudi R, Gill S, Biggs P, Dearnaley D, Ardern-Jones A, Dowe A, Shearer R, McLennan DL, Norman RL, Ghadirian P, Aprikian A, Ford D, Amos C, King TM, Labrie F, Simard J, Narod SA, Easton D and Foulkes WD (1998) Linkage analysis of chromosome 1q markers in 136 prostate cancer families. Am J Hum Genet 62: 653–658
Gibbs M, Chakrabarti L, Stanford JL, Goode EL, Kolb S, Schuster EF, Buckley VA, Shook M, Hood L, Jarvik GP and Ostrander EA (1999) Analysis of Chromosome 1q42.2–43 in 152 families with high risk of prostate cancer. Am J Hum Genet 64: 1087–1095
Grønberg H, Damber L, Damber JE and Iselius L (1997) Segregation analysis of prostate cancer in Sweden: support for dominant inheritance. Am J Epidemiol 146: 552–557
Hsieh CL, Oakley-Girvan I, Gallagher RP, Wu AH, Kolonel LN, Teh CZ, Halpern J, West DW, Paffenbarger RS, Jr and Whittemore AS (1997) Re: prostate cancer susceptibility locus on chromosome 1q: a confirmatory study. J Natl Cancer Inst 89: 1893–1894
Kruglyak L, Daly MJ, Reeve-Daly MP and Lander ES (1996) Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet 61: 347–353
Lange EM, Chen H, Brierley K, Perrone EE, Bock CH, Gillanders E, Ray ME and Cooney KA (1999) Linkage analysis of 153 prostate cancer families over a 30-cM region containing the putative susceptibility locus HPCX. Clin Cancer Res 12: 4013–4020
McIndoe RA, Stanford JL, Gibbs M, Jarvik GP, Brandzel S, Neal CL, Li S, Gammack JT, Gay AA, Goode EL, Hood L and Ostrander EA (1997) Linkage analysis of 49 high-risk families does not support a common familial prostate cancer-susceptibility gene at 1q24–25. Am J Hum Genet 61: 347–53
Monroe KR, Yu MC, Kolonel LN, Coetzee GA, Wilkens LR, Ross RK and Henderson BE (1995) Evidence of an X-linked or recessive genetic component to prostate cancer risk. Nat Med 1: 99–101
Neuhausen S, Farnham J, Kort E, Tavtigian SV, Skolnick MH and Cannon-Albright LA (1999) Prostate cancer susceptibility locus HPCl in Utah high-risk pedigrees. Hum Mol Genet 8: 2437–2442
O'Connell JR and Weeks DE (1995) The VITESSE algorithm for rapid exact multilocus linkage analysis via genotype set-recording and fuzzy inheritance. Nat Genet 11: 402–408
Schaid DJ, McDonnell SK, Blute ML and Thibodeau SN (1998) Evidence for autosomal dominant inheritance of prostate cancer. Am J Hum Genet 62: 1425–1438
Schäffer AA, Gupta SK, Shriram K and Cottingham RW, Jr (1994) Avoiding recomputation in linkage analysis. Hum Hered 44: 225–237
Smith JR, Freije D, Carpten JD, Gronberg H, Xu J, Isaacs SD, Brownstein MJ, Bova GS, Guo H, Bujnovszky P, Nusskern DR, Damber JE, Bergh A, Emanuelsson M, Kallioniemi OP, Walker-Daniels J, Bailey-Wilson JE, Beaty TH, Meyers DA, Walsh PC, Collins FS, Trent JM and Isaacs WB (1996) Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science 274: 1371–1374
Steinberg GD, Carter BS, Beaty TH, Childs B and Walsh PC (1990) Family history and the risk of prostate cancer. Prostate 17: 337–347
Suarez BK, Lin J, Burmester JK, Broman KW, Weber JL, Banerjee TK, Goddard KA, Witte JS, Elston RC and Catalona WJ (2000) A genome screen of multiplex sibships with prostate cancer. Am J Hum Genet 66: 933–944
Thibodeau SN, Wang Z, Tester DJ, French AJ, Schroeder JJ, Bissonet AS and Roberts SG (1997) Linkage analysis at the HPC1 locus in hereditary prostate cancer families. Am J Hum Genet 61: A297
Whittemore AS, Lin IG, Oakley-Girvan I, Gallagher RP, Halpern J, Kolonel LN, Wu AH and Hsieh CL (1999) No evidence of linkage for chromosome 1q42.2–43 in prostate cancer. Am J Hum Genet 65: 254–256
Xu JF, Meyers D, Freije D, Isaacs S, Wiley K, Nusskern D, Ewing C, Wilkens E, Bujnovszky P, Bova GS, Walsh P, Isaacs W, Schleutker J, Matikainen M, Tammela T, Visakorpi T, Kallioniemi OP, Berry R, Schaid D, French A, McDonnell S, Schroeder J, Blute M, Thibodeau S and Trent J (1998) Evidence for a prostate cancer susceptibility locus on the X chromosome. Nat Genet 20: 175–179
Xu J International Consortium for Prostate Cancer Genetics (2000) Combined analysis of hereditary prostate cancer linkage to 1q24–25: results from 772 hereditary prostate cancer families from the International Consortium for Prostate Cancer Genetics. Am J Hum Genet 66: 945–957
Author information
Authors and Affiliations
Consortia
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Singh, R., the ACTANE Consortium. No evidence of linkage to chromosome 1q42.2–43 in 131 prostate cancer families from the ACTANE Consortium. Br J Cancer 83, 1654–1658 (2000). https://doi.org/10.1054/bjoc.2000.1524
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1054/bjoc.2000.1524
Keywords
This article is cited by
-
The genetic epidemiology of prostate cancer and its clinical implications
Nature Reviews Urology (2014)
